You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hepatic triglyceride

Showing 1 - 25 of 3,580
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Insulin Resistance, Hypertriglyceridemia Trial in Amsterdam (Standardized Dinner, Premeal exercise)

Not yet recruiting
  • Insulin Resistance
  • Hypertriglyceridemia
  • Standardized Dinner
  • Premeal exercise
  • Amsterdam, Netherlands
    AMC Amsterdam
Feb 15, 2023

Non-Alcoholic Fatty Liver Disease, Non-alcoholic Steatohepatitis, Glucose Metabolism Disorders Trial in Aarhus (glucagon)

Completed
  • Non-Alcoholic Fatty Liver Disease
  • +2 more
  • glucagon
  • Aarhus, Danmark, Denmark
    Aarhus University Hospital
Nov 3, 2022

NAFLD, Type 2 Diabetes Trial in Aarhus N (High-fat mixed-meal tolerance test (HF-MMTT))

Recruiting
  • NAFLD
  • Type 2 Diabetes
  • High-fat mixed-meal tolerance test (HF-MMTT)
  • Aarhus N, Denmark
    Department of Endocrinology and Internal Medicine
May 23, 2022

HIV, Non-Alcoholic Fatty Liver Disease Trial in Brazil, United States (Semaglutide)

Recruiting
  • HIV Infections
  • Non-Alcoholic Fatty Liver Disease
  • Birmingham, Alabama
  • +8 more
Jan 28, 2022

NAFLD - Non-Alcoholic Fatty Liver Disease, Type 2 Diabetes Trial in Aarhus N (Hyperinsulinemic euglycaemic clamp)

Completed
  • NAFLD - Non-Alcoholic Fatty Liver Disease
  • Type 2 Diabetes
  • Hyperinsulinemic euglycaemic clamp
  • Aarhus N, Denmark
    Department of Endocrinology and Internal Medicine
May 23, 2022

Obesity, Insulin Resistance, Metabolically Healthy Obesity Trial in Saint Louis (People with Metabolically Unhealthy Obesity -

Recruiting
  • Obesity
  • +3 more
  • People with Metabolically Unhealthy Obesity - Low Calorie Diet
  • Saint Louis, Missouri
    Washington University School of Medicine
Jul 6, 2023

Diabetes Type 2 Trial in Sherbrooke (Bariatric surgery, Nicotinic Acid)

Not yet recruiting
  • Diabetes Mellitus Type 2
  • Bariatric surgery
  • Nicotinic Acid
  • Sherbrooke, Quebec, Canada
    centre de recherche du CHUS
Jun 27, 2023

Nutritional and Metabolic Diseases Trial in Oxford (Diet)

Recruiting
  • Nutritional and Metabolic Diseases
  • Diet
  • Oxford, United Kingdom
  • +1 more
Jul 31, 2023

Fatty Liver Trial in Helsinki (Low Carbohydrate Diet)

Recruiting
  • Fatty Liver
  • Low Carbohydrate Diet
  • Helsinki, Uusimaa, Finland
    Biomedicum 2U
Aug 23, 2021

Defining Circadian Metabolism in Non-alcoholic Fatty Liver

Recruiting
  • NAFLD
  • Lifestyle and weight loss advice
  • Oxford, United Kingdom
    University of Oxford
Jul 18, 2023

Pre-diabetes Trial in Québec (Low fat diet, High fat diet)

Recruiting
  • Pre-diabetes
  • Low fat diet
  • High fat diet
  • Québec, Quebec, Canada
    Institute of Nutrition and Functional Foods (INAF)
Jul 20, 2023

HIV-1-infection, Adiposity, Insulin Resistance Trial in Brazil, United States (Semaglutide)

Active, not recruiting
  • HIV-1-infection
  • +4 more
  • Birmingham, Alabama
  • +7 more
Dec 7, 2022

Insulin Resistance, Hyperinsulinemia, Dyslipidemias Trial in New York (drug, device, diagnostic test, dietary supplement)

Recruiting
  • Insulin Resistance
  • +2 more
  • Alpelisib 150 mg [Piqray], 2 overencapsulated tablets (total: 300 mg)
  • +4 more
  • New York, New York
    Columbia University Irving Medical Center
Feb 3, 2023

Kuwait Adult Diabetes Epidemiological Multidisciplinary Program

Recruiting
  • Diabetes Mellitus Type 2, Diabetes Mellitus Type 1
  • +2 more
    • Kuwait City, Kuwait
      Dasman Diabetes Institute
    Oct 30, 2023

    Type 2 Diabetes, Impaired Glucose Tolerance, Non-Alcoholic Fatty Liver Disease Trial (Semaglutide Pen Injector, Placebo)

    Not yet recruiting
    • Type 2 Diabetes Mellitus
    • +3 more
    • Semaglutide Pen Injector
    • Placebo
    • (no location specified)
    Jul 27, 2022

    Non-Alcoholic Fatty Liver Disease, Non Alcoholic Fatty Liver, Hepatic Steatosis Trial in Kyiv, Lviv (Probiotic lysate

    Recruiting
    • Non-Alcoholic Fatty Liver Disease
    • +3 more
    • Probiotic lysate (postbiotic and metabiotc)
    • Placebo
    • Kyiv, Ukraine
    • +3 more
    Mar 27, 2023

    Non-alcoholic Fatty Liver Disease Trial in Zagazig (Rybelsus Oral Product, Ozempic Injectable Product, Tocopherol and/or Actos)

    Recruiting
    • Non-alcoholic Fatty Liver Disease
    • Rybelsus Oral Product
    • +2 more
    • Zagazig, Sharkia, Egypt
      Zagazig University
    Apr 1, 2023

    Polycystic Ovarian Syndrome, Obesity, Hepatic Steatosis Trial in Aurora (Essential Amino Acid (EAA) Supplement, Placebo)

    Completed
    • Polycystic Ovarian Syndrome
    • +2 more
    • Essential Amino Acid (EAA) Supplement
    • Placebo
    • Aurora, Colorado
      University of Colorado, Anschutz Medical Campus
    Mar 4, 2022

    Adolescent Obesity Trial in New York (Fructose + Glucose Beverage)

    Recruiting
    • Adolescent Obesity
    • Fructose + Glucose Beverage
    • New York, New York
      Weill Cornell Medicial College
    Sep 16, 2022

    Non-Alcoholic Fatty Liver Disease Trial in Helsinki (bariatric surgery)

    Enrolling by invitation
    • Non-Alcoholic Fatty Liver Disease
    • bariatric surgery
    • Helsinki, Finland
      Biomedicum 2U
    Sep 20, 2022

    Metabolic Syndrome, Hypertriglyceridemia Trial in Sioux Falls (omega-3 acid ethyl esters, extended release niacin, )

    Completed
    Has Results
    • Metabolic Syndrome
    • Hypertriglyceridemia
    • omega-3 acid ethyl esters
    • +3 more
    • Sioux Falls, South Dakota
      Sanford Clinic Clinical Research Services
    Sep 28, 2021

    Obesity, Insulin Resistance Trial in Saint Louis (Weight loss with very low fat plant-based diet and regular exercise)

    Completed
    • Obesity
    • Insulin Resistance
    • Weight loss with very low fat plant-based diet and regular exercise
    • Saint Louis, Missouri
      Washington University in St. Louis School of Medicine
    Dec 5, 2022

    Fatty Liver, Nonalcoholic Trial (SGLT2 inhibitor)

    Not yet recruiting
    • Fatty Liver, Nonalcoholic
    • SGLT2 inhibitor
    • (no location specified)
    Oct 31, 2023

    Fat Metabolism in OSA and COPD

    Completed
    • Obstructive Sleep Apnea
    • +2 more
      • College Station, Texas
        Texas A&M University
      Feb 3, 2022

      Obesity, Insulin Resistance Trial in Saint Louis (Metabolically abnormal obese - Mediterranean diet, Metabolically abnormal

      Recruiting
      • Obesity
      • Insulin Resistance
      • Metabolically abnormal obese - Mediterranean diet
      • +2 more
      • Saint Louis, Missouri
        Washington University School of Medicine
      Dec 12, 2022